Bisphosphonates Not Associated with Reduced Breast Cancer Risk (FREE)

By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD The bisphosphonates alendronate and zoledronic acid do not reduce the risk for breast cancer among postmenopausal women, according to findings from two randomized trials …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news